Kansas City academic transplant programme running since 1977, offering autologous, donor, half-matched and cord blood transplants plus CAR T-cell therapy.
The blood and marrow transplant (BMT) and cellular therapy programme of The University of Kansas Health System and The University of Kansas Cancer Center is an academic hospital service in Kansas City. It is not a private regenerative medicine clinic; it treats blood cancers and serious non-cancerous blood and immune disorders. The programme states it was established in 1977.
Transplant uses healthy blood-forming cells, taken from bone marrow or from the bloodstream, to rebuild a patient's blood and immune system after chemotherapy or radiotherapy. The programme offers autologous transplant using the patient's own cells, allogeneic transplant from a matched donor, syngeneic transplant from an identical twin, cord blood transplant, non-myeloablative (reduced-intensity) transplant, and haploidentical or half-matched transplant from a related donor for patients who cannot find a full match.
The centre is designated by the National Marrow Donor Program as a matched unrelated donor transplant centre and states it was the region's first BMT programme accredited by the Foundation for the Accreditation of Cellular Therapy. It also provides CAR T-cell therapy, in which a patient's own immune T cells are re-engineered to attack cancer, and photopheresis, a light-based blood treatment used in graft-versus-host disease. Clinical trials are available. Some care is given on an outpatient basis at the Richard and Annette Bloch Cancer Care Pavilion.
The programme page does not name individual doctors; a separate care team page lists the transplant specialists.
Care is delivered through The University of Kansas Health System in Kansas City, with outpatient transplant care at the Richard and Annette Bloch Cancer Care Pavilion. The programme telephone number is 913-588-1227. It is a National Marrow Donor Program designated matched unrelated donor centre and is accredited by the Foundation for the Accreditation of Cellular Therapy. Languages spoken and any dedicated international-patient service are not stated on the page reviewed.
No prices are published. Transplant and CAR T-cell therapy at this centre are normally billed to insurance or public programmes rather than paid privately; ask the financial counselling team about coverage.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.